Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.72 AUD | +1.48% | +2.57% | -22.94% |
May. 22 | Jarden Adjusts Sonic Healthcare Price Target to AU$26.19 From AU$28.88, Keeps at Neutral | MT |
May. 21 | Sonic Healthcare Forecasts AU$1.6 Billion EBITDA, AU$8.9 Billion of Revenue for FY2024 | MT |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company benefits from high valuations in earnings multiples.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-22.94% | 7.77B | B+ | ||
+76.66% | 4.51B | C+ | ||
+6.87% | 2.76B | B- | ||
-2.63% | 2.67B | - | ||
-49.74% | 2.09B | B- | ||
-18.42% | 1.72B | C- | ||
-19.40% | 1.49B | A- | ||
+18.29% | 1.22B | B+ | ||
-44.77% | 1.12B | C+ | ||
+20.68% | 1.05B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SHL Stock
- Ratings Sonic Healthcare Limited